Tympanoplasty with Ossiculoplasty — Cost, Top Hospitals & Success Rates | MyMedicPlus

Tympanoplasty — in its broadest surgical sense — refers to reconstruction of the tympanic membrane (TM) and the middle-ear sound-conducting mechanism. When the procedure extends to repair or replacement of damaged ossicles (malleus, incus, stapes), it is termed tympanoplasty with ossiculoplasty and corresponds to Wullstein types II through IV. When cholesteatoma or chronic mastoid disease coexists, mastoidectomy is performed concurrently, adding a mastoid dimension to the procedure.

The ossicular chain — three of the smallest bones in the human body — transmits vibration from the tympanic membrane across the air-filled middle-ear space to the oval window and fluid-filled cochlea. Erosion of these ossicles by chronic suppurative otitis media, cholesteatoma, or trauma disrupts this mechanical amplification, producing conductive hearing loss that can reach 50–60 dB. Ossiculoplasty aims to re-establish this chain using either residual ossicles (reshaped and repositioned as autografts) or prosthetic devices.

Two principal ossicular prostheses are used in modern otology:

• PORP (Partial Ossicular Replacement Prosthesis): A titanium or hydroxyapatite strut connecting the TM or malleus handle to the stapes head. Used when the stapes superstructure (head, crura) is intact.
• TORP (Total Ossicular Replacement Prosthesis): A longer prosthesis resting on the stapes footplate when the stapes superstructure is absent. Requires careful alignment to avoid extrusion.

Both prostheses are available in titanium (lightweight, biocompatible, MRI-safe), hydroxyapatite (osseointegrative), and plastipore variants. Titanium TORPs and PORPs have largely replaced older materials due to their superior extrusion resistance and acoustic efficiency. A cartilage cap placed between the prosthesis head and the TM graft significantly reduces the extrusion rate from approximately 15–20% to under 5%.

When cholesteatoma is identified — a self-perpetuating epithelial cyst that erodes bone through enzymatic activity — complete removal of the cholesteatoma takes precedence over hearing reconstruction, with ossiculoplasty often staged to a second operation to ensure disease clearance.

Tympanoplasty with ossicular reconstruction addresses middle-ear conditions causing significant conductive hearing loss that exceeds what a simple TM repair (myringoplasty) can correct:

Chronic Suppurative Otitis Media with Ossicular Erosion

Long-standing chronic ear disease erodes the incus — the most vulnerable ossicle due to its tenuous blood supply — particularly at the lenticular process (its contact point with the stapes). Erosion of the incus long process is the most common ossicular defect encountered at surgery, typically corrected with a partial ossicular replacement prosthesis (PORP) or a reshaped remnant incus interposed between the malleus handle and stapes head.

Cholesteatoma (Atticoantral CSOM)

Cholesteatoma is an expanding epithelial cyst arising from the pars flaccida or posterior margin of the TM that erodes the ossicular chain, mastoid air cells, tegmen, and — in advanced cases — the facial nerve canal, semicircular canals, and dura. Surgical management requires complete cholesteatoma removal (tympanoplasty + mastoidectomy) followed by staged ossicular reconstruction 9–12 months later, once disease clearance is confirmed by second-look surgery or high-resolution CT/DWI MRI.

Traumatic Ossicular Disruption

Head trauma, barotrauma, and blast injuries can dislocate or fracture the ossicular chain without perforating the tympanic membrane — an injury that can be missed if only otoscopy and audiometry are performed. Incudostapedial dislocation is the most common traumatic ossicular injury, resulting in a maximal conductive loss (50–60 dB) with an intact drum. Reconstruction requires open middle-ear exploration and ossiculoplasty.

Tympanosclerosis

Calcium phosphate deposits within the TM and middle ear from repeated otitis media can fix the ossicular chain (particularly the stapes footplate — otosclerosis-like). Surgical mobilisation or replacement of affected ossicles improves hearing.

Congenital Ossicular Anomalies

Congenital fixation or absence of ossicles (often associated with microtia and external canal atresia) requires meticulous reconstruction in specialised paediatric otology centres.

Patient selection for tympanoplasty with ossiculoplasty requires careful audiological and imaging assessment to optimise outcomes and minimise surgical risk.

Audiological Prerequisites

• Conductive hearing loss with air-bone gap (ABG) ≥20 dB on pure-tone audiometry; surgery is most beneficial when ABG ≥30 dB
• Speech discrimination score ≥60% in the operative ear (adequate cochlear reserve to benefit from conductive correction)
• Contralateral ear hearing level documented; surgery on an only-hearing ear requires specialist counselling

Radiological Assessment

High-resolution CT of the temporal bones (HRCT) is mandatory when ossicular pathology, cholesteatoma, or mastoid disease is suspected. CT defines ossicular chain integrity, the position of the facial nerve, tegmen height, sigmoid sinus position, and degree of mastoid pneumatisation — all critical to surgical planning. Diffusion-weighted MRI (DWI non-EPI or PROPELLER sequences) has high sensitivity for cholesteatoma detection and is used for surveillance following primary surgery without second-look exploration.

Fitness for General Anaesthesia

Most tympanoplasties with ossiculoplasty are performed under general anaesthesia due to the duration and precision required. Pre-operative cardiac and respiratory assessment is required for patients over 60 or those with significant comorbidity. Local anaesthesia with monitored sedation is rarely sufficient for complex middle-ear work.

Absence of Active Infection

The ear must be dry and free from suppurative discharge for a minimum of 6–8 weeks pre-operatively, confirmed by microscopic examination. Persisting discharge despite topical antibiotics requires culture-directed systemic treatment before surgery is scheduled.

Patients with diabetes, immunosuppression, or on anticoagulation require specific pre-operative optimisation. Those with a history of radiation to the temporal region have significantly higher wound healing and infection risk and should be managed by experienced otologists.

The most critical surgical decision in tympanoplasty involving mastoid disease or cholesteatoma is whether to preserve or remove the posterior bony canal wall. This choice defines two fundamentally different operations with different post-operative maintenance requirements and long-term outcomes.

Canal Wall Up (CWU) Tympanoplasty with Mastoidectomy

In the CWU or intact canal wall technique, the posterior external auditory canal wall is preserved while the mastoid air cells are exenterated from behind (a cortical or radical mastoidectomy). The middle ear and mastoid are connected through a posterior tympanotomy (facial recess approach). Ossiculoplasty is performed in the same sitting or staged. Advantages include a self-cleaning, anatomically normal ear canal and no need for long-term cavity care. The principal disadvantage is that residual cholesteatoma hidden behind the intact canal wall cannot be inspected without re-operation; second-look surgery is therefore typically planned at 9–12 months, or DWI MRI surveillance is employed annually.

Canal Wall Down (CWD) Tympanoplasty / Modified Radical Mastoidectomy

The posterior canal wall is removed, creating a single large mastoid cavity open to the ear canal (a meatoplasty is performed to widen the meatus for access). This approach exteriorises all disease and is preferred for extensive cholesteatoma, revision surgery after CWU recurrence, patients unable to attend regular follow-up, and those with an only-hearing ear where the risk of re-exploration must be minimised. The CWD cavity requires life-long self-care (annual microsuction debridement in clinic) and is susceptible to water intolerance and recurrent otitis externa if not properly managed.

Ossiculoplasty Staging

When cholesteatoma is present, ossicular reconstruction is usually deferred to a second-stage procedure 9–12 months after initial disease clearance. This ensures the middle ear is free of residual disease before a prosthesis is implanted. In selected cases of simple ossicular erosion without cholesteatoma, single-stage ossiculoplasty using a PORP (intact stapes superstructure) or TORP (absent stapes arch) can be performed with comparable results. Autologous incus (reshaped) remains an excellent ossicular substitute when available.

The goals of tympanoplasty with ossiculoplasty are hearing restoration, eradication of active disease, creation of a safe and dry ear, and prevention of serious intracranial and labyrinthine complications from advancing middle-ear pathology.

Hearing Restoration

Successful ossiculoplasty closes the air-bone gap to within 20 dB in 70–85% of patients when using titanium prostheses with cartilage capping. PORP outcomes are consistently better than TORP because the stapes superstructure provides a stable fulcrum; TORP results are more variable, with ABG closure within 20 dB in 60–75% of cases. Residual gaps reflect prosthesis migration, middle-ear adhesions, or inadequate cartilage capping. Hearing gains are typically sustained at 5-year follow-up in the majority of patients without recurrent cholesteatoma.

Disease Eradication and Safety

Complete cholesteatoma removal eliminates the risk of serious complications including labyrinthine fistula (causing sudden sensorineural loss and vertigo), facial nerve paralysis from nerve canal erosion, meningitis, epidural abscess, and lateral sinus thrombosis. For patients presenting with active cholesteatoma, surgery is not elective but medically indicated — the alternative is progressive bone destruction with inevitably worse surgical outcomes and potentially life-threatening intracranial extension.

Dry Ear and Quality of Life

A well-reconstructed, epithelialised middle ear eliminates the chronic discharge, malodour, and recurrent infection that profoundly impair quality of life in patients with CSOM. Patient-reported outcomes show significant gains in social interaction, occupational function, and psychological wellbeing following successful tympanoplasty.

In children, correcting significant conductive hearing loss improves language acquisition, classroom performance, and cognitive development — outcomes that extend far beyond the immediate surgical benefit.

Tympanoplasty with ossiculoplasty carries a higher risk profile than simple myringoplasty owing to deeper middle-ear manipulation and, when mastoidectomy is performed, proximity to critical neurovascular structures.

Common (1–10%)

• Residual or recurrent cholesteatoma: The most frequent complication in CWU surgery, occurring in 10–25% of cases. Requires scheduled second-look surgery or serial DWI MRI surveillance.
• Prosthesis extrusion: A TORP or PORP may migrate and erode through the TM graft, particularly if no cartilage cap was used. Rates are 5–15% without cartilage and <5% with cartilage protection.
• Graft failure: TM graft perforation or non-take; more common in complex cases with poor ET function.
• Hearing not improved or worsened (conductive): Prosthesis malposition, middle-ear adhesions, or residual tympanosclerosis may prevent expected hearing gains.

Uncommon (0.1–1%)

• Sensorineural hearing loss: Inner ear damage from acoustic trauma, suction, drill vibration, or oval window manipulation; risk is <1% in experienced hands.
• Facial nerve injury: The facial nerve is at particular risk in CWD cases, revision surgery, and when cholesteatoma has eroded its bony canal. Permanent palsy is rare (<0.1%) in specialist centres.
• Chorda tympani injury: Taste disturbance; usually transient but may be permanent in 3–5% of cases.
• Labyrinthine fistula: Inadvertent opening of a semicircular canal or cochlea, resulting in sudden SNHL and vertigo; extremely rare with modern micro-drilling techniques.

Mastoidectomy-Specific Risks

• Dural injury with cerebrospinal fluid (CSF) leak (rare; usually self-sealing)
• Sigmoid sinus injury (rare; controlled with packing)
• Cavity problems in CWD surgery: recurrent otitis externa, retained debris, difficult microsuction, water intolerance

Patients should receive realistic pre-operative counselling: hearing outcomes from ossiculoplasty are less predictable than from myringoplasty alone, and a second operation may be needed either for disease surveillance or prosthesis revision.

Recovery from tympanoplasty with ossiculoplasty and mastoidectomy is more prolonged than simple myringoplasty. Patients should anticipate a 6–8 week period of restricted activity and water avoidance, with full audiological assessment deferred until the middle ear has fully settled.

Hospital and Immediate Post-Operative Period

Most patients are admitted for one to two nights following a combined tympanoplasty-mastoidectomy. A mastoid dressing (bandage) is applied for 24–48 hours. Mild to moderate post-auricular pain is managed with regular analgesia. Dizziness and disequilibrium are common for 24–48 hours due to middle-ear manipulation; persistent or severe vertigo requires urgent assessment. Patients are discharged with instructions to avoid nose-blowing, heavy lifting, and any activity that increases intracranial pressure.

Suture Removal and First Microsuction (Week 2–3)

Post-auricular sutures are removed at 10–14 days. The surgeon performs gentle microsuction to remove debris and assess the graft. Hearing at this stage may be muffled by residual canal packing — patients should not interpret this as a poor result.

Audiological Assessment (Week 6–8)

Pure-tone audiometry is performed once the middle ear has stabilised. The prosthesis position is assessed by microscopy and, if concern exists about positioning, HRCT may be requested. Hearing aid assessment is arranged for patients in whom the achieved air-bone gap remains >30 dB.

Disease Surveillance for Cholesteatoma (Months 9–12)

Patients who underwent CWU surgery for cholesteatoma are typically scheduled for either a planned second-look operation or diffusion-weighted MRI at 9–12 months to exclude residual disease. If the MRI is negative and the ear is dry with a well-healed TM, second-look surgery may be deferred with continued annual MRI surveillance.

Long-term CWD Cavity Care

Patients with canal-wall-down cavities attend for annual microsuction debridement. They are advised never to allow water into the mastoid bowl (custom-fitted ear molds or silicone plugs during swimming/showering). Recurrent otitis externa within the cavity is treated with aural toilet and topical antibiotic-steroid drops.

Tympanoplasty with ossiculoplasty is a specialist procedure that is significantly more expensive than simple myringoplasty owing to longer operative time, implant costs, and typically longer hospital stay.

Approximate Cost Ranges by Region

• United States: USD 15,000–35,000 (combined tympanoplasty + mastoidectomy without insurance)
• United Kingdom (private): GBP 6,000–12,000
• India (JCI/NABH hospitals): USD 2,500–6,000 (type II–III with PORP); USD 4,000–9,000 (CWD mastoidectomy + ossiculoplasty)
• Thailand: USD 4,000–9,000
• Turkey: USD 3,500–8,000
• Singapore: USD 7,000–15,000

Key Cost Drivers

• Prosthesis type: Titanium prostheses (TORP/PORP) cost USD 300–900 per implant at list price; this is passed on to the patient in most private settings
• Mastoidectomy: Adding mastoid surgery substantially increases operative time, theatre costs, and anaesthesia fees
• Staged procedures: Cholesteatoma cases requiring two operations (primary clearance + second-look ossiculoplasty) approximately double the total cost
• Imaging: HRCT of temporal bones (USD 300–1,200) and DWI MRI for cholesteatoma surveillance (USD 500–1,500) add to the total episode cost
• Surgeon subspecialisation: Otologists or neurotologists with fellowship training in complex ear surgery command premium fees — appropriate for complex cholesteatoma or revision cases

Patients travelling internationally for this procedure should verify that the quoted price includes the prosthesis implant cost, all surgical and anaesthetic fees, hospital stay, and a minimum of two post-operative follow-up visits. Any second-look procedure should be costed separately and clearly agreed in advance.

Alternatives to tympanoplasty with ossiculoplasty depend on the underlying diagnosis. For cholesteatoma and ossicular fixation from chronic disease, surgery is almost universally the correct treatment — non-surgical alternatives do not halt progressive bone destruction. However, for patients with pure conductive hearing loss who are medically unfit for surgery, or who wish to defer or decline surgical intervention, the following options provide meaningful quality-of-life benefit.

Conventional Hearing Aids

Behind-the-ear (BTE) or receiver-in-canal (RIC) hearing aids effectively amplify sound to compensate for conductive hearing loss up to 60 dB. Modern hearing aids offer Bluetooth connectivity, rechargeable batteries, and high signal fidelity. For patients with a significant conductive component and intact cochlear function, conventional aids deliver excellent speech intelligibility gains without surgical risk.

Bone-Anchored Hearing Aids (BAHA)

A titanium implant placed in the skull behind the ear conducts sound vibrations via bone to the cochlea, bypassing the middle ear entirely. BAHA is an excellent alternative for patients with bilateral conductive loss, chronic otitis externa precluding an ear canal device, canal atresia, or a single-sided sensorineural deafness. The Osia, Ponto, and BAHA Attract systems offer both percutaneous and transcutaneous (magnetic) coupling options.

Active Middle Ear Implants

Devices such as the Vibrant Soundbridge (MED-EL) use a floating mass transducer attached to the ossicular chain or round window membrane to drive cochlear fluids directly. These are particularly valuable in cases where conventional aids cannot be worn (chronic otorrhoea, canal stenosis) and where anatomy precludes a BAHA. They provide excellent hearing restoration with minimal occlusion effect but require surgical implantation.

Observation (Cholesteatoma — Not Recommended)

Watchful waiting is not appropriate for cholesteatoma. Progressive bone erosion is inevitable, and delayed surgery results in more extensive disease, worse hearing outcomes, and higher rates of serious complications including facial palsy and meningitis. Early surgical intervention is the standard of care.